Chi Ma

The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9

Shun Zhang, Xiaohua Jiang, Chun Song, 2022, Canadian journal of gastroenterology & hepatology.

Prognostic Significance of NLR, PLR, LMR and Tumor Infiltrating T Lymphocytes in Patients Undergoing Surgical Resection for Hilar Cholangiocarcinoma

G. Tan, Z. Ning, Chi Ma, 2022, Frontiers in Oncology.

Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer

K. Tao, Gang Wu, Peng Zhang, 2021, Journal for ImmunoTherapy of Cancer.

Metformin treatment rescues CD8+ T cell response to immune checkpoint inhibitor therapy in mice with NAFLD.

X. Wang, T. Greten, J. Kabat, 2022, Journal of hepatology.

Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial.

G. Jiang, Q. Fan, Feng Zhao, 2022, The lancet. Gastroenterology & hepatology.

Efficacy, Safety, and Health-Related Quality of Life with Camrelizumab Plus Pemetrexed and Carboplatin as First-Line treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer with Brain Metastases (CAP-BRAIN): A Multicentre, Open-Label, Single-Arm, Phase 2 Study.

Likun Chen, X. Hou, Chengzhi Zhou, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.